Delivery Order SPE2DB20D3103-SPE2DB25FL5W3

Award Date 11/7/24
Potential Completion Date 11/8/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,427.84 firm fixed-price delivery order is for the supply of ZAFEMY 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The award has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZAFEMY 150-35 MCG/DAY PATCH 3S, a medical product, with a ceiling value of $2,656.15 and a completion date of June 27, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,993.13 firm-fixed-price delivery order is for the supply of the drug product ZAFEMY 150-35 MCG/DAY PATCH 3S, with a period of performance through September 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a $7,210.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ZAFEMY 150-35 MCG/DAY PATCH 3S. The contract has an ultimate completion date of June 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.32, is for the supply of the drug ZAFEMY 150-35 MCG/DAY PATCH 3S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,753.71, is for the delivery of ZAFEMY 150-35 MCG/DAY PATCH 3S, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.02 firm-fixed-price delivery order is for the supply of ZAFEMY 150-35 MCG/DAY PATCH 3S, a medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,556.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order for the pharmaceutical product "ZAFEMY 150-35 MCG/DAY PATCH 3S" and has a firm fixed price structure with an ultimate completion date of January 31, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4566144071 ZAFEMY 150-35 MCG/DAY PATCH 3S. The $7,404.77 firm fixed price contract was awarded by the Defense Logistics Agency, a defense agency, on October 18, 2024 with an ultimate completion date of October 21, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This federal contract award, valued at $3,396.27, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL5W3
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,417.83 firm fixed price delivery order is for the supply of ZAFEMY 150-35 MCG/DAY PATCH 3S medical patches. The contract has an ultimate completion date of November 8, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:28 PM